Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
348 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (6)
  • Closed (16)

Medical Condition

  • Show all (68)
  • Addiction (1)
  • Cancer (2)
  • COVID-19 (Coronavirus) (2)
  • (-) Healthy Volunteers (22)
  • Infectious Disease (34)
  • Kidney Disease (1)
  • Liver Disease (1)
  • Pediatrics (1)
  • Transplant (4)
Displaying 1 - 22 of 22

HIV Vaccine: HVTN 144 - Healthy Volunteers

Condition: Healthy Volunteers
Investigator: Magdalena Sobieszczyk, MD
Status: Currently Recruiting
The HIV Vaccine Trials Network (HVTN) and Columbia University Irving Medical Center (CUIMC) are conducting a study to learn about the safety and effectiveness of an experimental HIV vaccine. The study vaccine is a protein vaccine called N332-GT5 gp140. It includes a manmade protein that looks…
Read More

DUO: Mobile Health tool Focus Groups to support HIV PrEP among Young Latino/e/x Cisgender Men and nonbinary Persons assigned Male at birth

Condition: Healthy Volunteers
Investigator: Ellen Morrison, MD, MPH
Status: Currently Recruiting
Come and talk with us about HIV prevention! HPTN 113-01/DUO is a series of 3 focus group discussions with young Latino/e/x cisgender men and gender nonbinary persons assigned male at birth (AMAB), who have sex with men. The focus groups will be conducted in English or Spanish, include 5-10 people, and be audio-recorded.…
Read More

HIV Vaccine Study: HVTN 312

Condition: Healthy Volunteers
Investigator: Magdalena Sobieszczyk, MD
Status: Currently Recruiting
The HIV Vaccine Trials Network, Division of AIDS, and Columbia University Irving Medical Center are conducting a trial to learn about the safety and effectiveness of two new experimental HIV vaccines. This is a first-in-human phase 1 clinical trial where we will be testing 2 study vaccines,…
Read More

HPTN 103/ Purpose 4: An HIV Prevention Study for People Who Inject Drugs

Condition: Healthy Volunteers
Investigator: Ellen Morrison, MD, MPH
Status: Currently Recruiting
PrEP (Pre-Exposure Prophylaxis) is medication that is taken to prevent HIV if a person is exposed to HIV. Research is ongoing to develop PrEP medications that may be both convenient and effective. This study is important because people who inject drugs face multiple overlapping individual, social…
Read More

PrEP for Women (HPTN 102/Purpose 3): An HIV Prevention Study for Women to Evaluate an Investigational Twice a Year PrEP Injection

Condition: Healthy Volunteers
Investigator: Ellen Morrison, MD, MPH
Status: Currently Recruiting
PrEP (Pre-Exposure Prophylaxis) is medication that is taken to prevent HIV if a person is exposed to HIV. Research is ongoing to identify PrEP medications that are both convenient and effective. This study is important because women in many areas of New York City have high rates of…
Read More

HIV Prevention Study

Condition: Healthy Volunteers
Investigator: Magdalena Sobieszczyk, MD
Status: Currently Recruiting
We are looking for individuals 18 to 60 years old who are interested in learning more about HIV prevention and biomedical research studies. We will ask you to complete a brief questionnaire to find out if we can schedule you for a one-on-one, 1.5-hour education visit to learn about the research we do. The education visit will…
Read More

HVTN 302: HIV Vaccine Trial for Healthy, HIV Negative Adults, Ages 18-55

Condition: Healthy Volunteers
Investigator: Magdalena Sobieszczyk, MD
Status: Closed
The HIV Vaccine Trials Network, Division of AIDS, and Columbia University Irving Medical Center are conducting a trial to learn about the safety and effectiveness of 3 experimental HIV vaccines. This is a first-in-human phase 1 clinical trial of experimental HIV…
Read More

The purpose of this study is to test a combination of vaccines against HIV. We want to see if the vaccines prevent people from getting HIV.

Condition: Healthy Volunteers
Investigator: Julie Franks, PhD
Status: Closed
Almost 40,000 people get HIV in the U.S. each year and almost all infections occur via sexual contact, especially male-to-male contact. The number of new infections has decreased slightly each year; however, we need other HIV prevention tools, including an effective HIV…
Read More

HVTN 137: HIV Vaccine Trial for Healthy, HIV Negative Adults, Ages 18-50

Condition: Healthy Volunteers
Investigator: Magdalena Sobieszczyk, MD
Status: Closed
The purpose of the study is to test an experimental HIV vaccine. The study vaccine is made from two parts: a man-made piece of protein that looks like a protein found on the outside of HIV and an adjuvant. An adjuvant is a substance that helps the immune system respond better. The study will see…
Read More

Interested in Improving HIV Prevention & Linkage to Care? Join mLab Study! Help Us Research an HIV Testing App from Home

Condition: Healthy Volunteers
Investigator: Rebecca Schnall, PhD, RN
Status: Closed
The mLab study at Columbia University is looking for young cisgender men or trans women who are 18-29 years old and have sex with guys. Eligible individuals can earn up to $170 by participating in this LGBTQ+ health study and completing 3 online surveys over the course of 1 year. See if you're eligible to participate! Questions? Text us: 347-743-0104
Read More

HIV Vaccine Study Among 18-60 year-old Sexually Active Men or Transgender Individuals

Condition: Healthy Volunteers
Investigator: Magdalena Sobieszczyk, MD
Status: Closed
Almost 40,000 people get HIV in the U.S. each year and almost all occur via sexual contact, especially male-to-male contact. The number of new infections has decreased slightly each year, however, we need other HIV prevention tools, such as developing a greatly, effective …
Read More

HIV prevention study: HVTN 120

Condition: Healthy Volunteers
Investigator: Magdalena Sobieszczyk, MD
Status: Closed
We are working on a new HIV vaccine study that builds on past success and other ongoing studies. This new study is called HVTN 120 and is testing a vaccine for HIV prevention. The Thai Trial has been the only study where the vaccines were partially protective in preventing…
Read More

Antibodies for HIV Prevention

Condition: Healthy Volunteers
Investigator: Magdalena Sobieszczyk, MD
Status: Closed
We are looking for healthy, HIV-negative individuals 18 to 50 years old who are interested in our studies that test antibodies for HIV prevention. Antibodies are one of the natural ways that our bodies fight or prevent infection. We are testing an antibody called VRC07-523LS against…
Read More

Study to Help Transgender Women use HIV Prevention Services Effectively

Condition: Healthy Volunteers
Investigator: Julie Franks, PhD
Status: Closed
We are conducting a study to see if offering pre-exposure prophylaxis (PrEP) together with another health service that many transgender women use or would like to use, gender-affirming hormone therapy (GAHT), improves HIV-related outcomes, as compared to offering PrEP and referring study participants to get GAHT at area health…
Read More

Bispecific Antibody Study: 18-60-year-old, Healthy & HIV-Negative Volunteers

Condition: Healthy Volunteers
Investigator: Magdalena Sobieszczyk, MD
Status: Closed
Antibodies are one of the natural ways that our bodies fight or prevent infection. Were testing an antibody to find out if its safe, if it doesn't make people feel uncomfortable and to find out what may be the best dose if its given by IV infusion or sub-cutaneous injection. You cannot get HIV from the Bispecific Antibody.…
Read More

Improving Online Recruitment for HIV-Related Studies

Condition: Healthy Volunteers
Investigator: Alex Carballo-Dieguez, MD
Status: Closed
This study will help scientists to understand the best ways to recruit and engage a wide variety of people (HIV-positive and HIV-negative) in HIV-related studies, using online recruitment methods. In this study you will be asked about topics including your…
Read More

A Study Among 18-50 Year Old People Who Do NOT Have HIV Comparing an Antibody in Combination with 3 Different Antibodies (CUIMC)

Condition: Healthy Volunteers
Investigator: Magdalena Sobieszczyk, MD
Status: Closed
Antibodies are one of the natural ways that our bodies fight or prevent infection. Were testing an antibody to find out if its safe, if they don't make people feel uncomfortable, how these study antibodies move throughout the body, and to measure antiviral activity. You cannot get HIV from the study antibody. Firstly, request…
Read More

A Study to Test the Safety of Monoclonal Antibodies in HIV-uninfected Participants (ages 18-50) (Harlem)

Condition: Healthy Volunteers
Investigator: Cassia Wells, MD
Status: Closed
Antibodies are one of the natural ways that our bodies fight or prevent infection. We're testing an antibody to find out if it's safe, if they don't make people feel uncomfortable, how these study antibodies move throughout the body, and to measure antiviral activity. You cannot get HIV from the study antibody. First, request…
Read More

Study of Biological Aging Among African Americans (Healthy Volunteers)

Condition: Healthy Volunteers
Investigator: Stephen Arpadi, MD, MS
Status: Closed
We are seeking healthy volunteers (HIV-negative) for a study seeing if HIV is associated with faster biological aging among older African American adults, whether faster biological age is related to health conditions that typically occur in older people and whether these conditions might be due…
Read More

Gonorrhea Prevention Vaccine Study (Bexsero)

Condition: Healthy Volunteers
Investigator: Sharon Mannheimer, MD
Status: Closed
We are looking for adult volunteers to help us see if the FDA-approved Bexsero meningitis B vaccine can prevent people from getting gonorrhea infections. There are over 580,000 cases of gonorrhea diagnosed annually in the United States. Gonorrhea infections can significantly affect short and long-term reproductive health and contribute to increasing…
Read More

Oral Health and Bone Loss in Women and Men (Healthy Volunteers)

Condition: Healthy Volunteers
Investigator: Michael Yin, MD
Status: Closed
The study is exploring the impact of gender, age, HIV infection, and menopausal status on dental health. The study is open to men and women, ages 35-70.
Read More

Online Men's Health Survey

Condition: Healthy Volunteers
Investigator: Rebecca Schnall, PhD, RN
Status: Closed
Take the Online Men's Health Survey (OMHS) today! Human Immunodeficiency Virus (HIV) and syphilis disproportionately affect men who have sex with men (MSM); however, this phenomenon is not well understood and is understudied in the United States. The OMHS study is being performed to help improve STI prevention and treatment…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science